Patrick Frost, PhD

Patrick Frost, PhD

Jan 13, 2016

Group 6 Copy 51
-1
    Please wait...

    About This Project

    BBRI and Los Angeles VA Medical Center

    Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can we identify spawning events in deepwater snappers and groupers?

    Nearshore deepwater fisheries are expanding in the Caribbean as coastal fisheries decline. Because deepwater...

    How are the repetitive circular DNA sequences present on chloroplasts created?

    The Inverted Sequence (IR) of some plants is one of well-known kind of special sequences. But, until now...

    Is mycelium clay a suitable replacement for large scale gypsum polymer structures?

    Myco-composites are sustainable and renewable alternatives to toxic petroleum plastics but require monitored...

    Backer Badge Funded